PersPectives
the starting point is a known oncoprotein or a phytochemical with proven anticancer activity (FIG. 1). The first is a target-based approach beginning with target protein
selection on the basis of data ideally obtained from an RNA interference (RNAi) screen (reviewed in REFs 27–29), as well as in vitro, ex vivo and in vivo models. Potential phyto-Ki Won Lee, Ann M. Bode and Zigang Dongchemical candidates can then be selected by
in silico virtual screening, based on natural
Abstract | Although successful for a limited number of tumour types, the efficacy chemical libraries30. An in silico screen
of cancer therapies, especially for late-stage disease, remains poor overall. Many requires diverse ligand databases, such as the have argued that this could be avoided by focusing on cancer prevention, which (see Further information)31, has now entered the arena of targeted therapies. During the process of identifying which contains ‘ready-to-dock’ searchable preventive agents, dietary phytochemicals, which are thought to be safe for human libraries of 4.6 million three-dimensional
compounds ranging from hit-to-lead can-use, have emerged as modulators of key cellular signalling pathways. The task now didates to FDA-approved compounds with is to understand how these chemicals perturb these pathways by modelling their vendor links to order31. The interactions with their target proteins.(see Further information) is another exten-sive library of searchable natural compounds Despite the intensive efforts and substantial signalling. We also address the progress, that are also available for purchase.advances that have occurred through focus-limitations and future directions in target-The X-ray crystallographic structures of
ing on improving treatments, cancer is still driven phytochemical cancer prevention a protein of interest either alone or bound a leading cause of death worldwide. Since research.to an inhibitor or ligand are crucial in the idea of cancer chemoprevention was the process of identifying protein–small
12
introduced by Sporn and Wattenberg et al., Phytochemical-derived anticancer drugsmolecule interactions and designing more the hope for overcoming cancer has started The effort to develop anticancer drugs specific inhibitors. Protein crystal structures to change from one of treatment to one of began in the 1950s. In 1955, the US National that have been resolved are deposited in prevention. The World Health Organization Cancer Institute (NCI) established the the Research Collaboratory for Structural (WHO) indicates that one-third of all cancer Cancer Chemotherapy National Service Bioinformatics (RCSB) protein data bank deaths are preventable and that diet is closely Center to screen natural and synthetic com-(; see Further information)32. However,
linked to cancer prevention (see REF. 3 for pounds that effectively induced cancer cell if a protein crystal structure with a resolu-14a review). On the basis of this idea, and death. One of the most successful FDA-tion average of about 2.0 Å does not exist, numerous epidemiological findings, atten-approved drugs to come from this initiative or the structure has not been resolved,
15
tion has centred on dietary phytochemicals is paclitaxel (Taxol; Bristol-Myers Squibb), homology modelling methods are used to as an effective intervention in cancer devel-which was isolated from the bark of the create a suitable structure with which to
opment. However, the failure of large-scale Pacific Yew tree. Examples of FDA-approved work. Homology modelling between pro-clinical trials in the 1990s, including the anticancer therapeutic agents derived from teins requires that they possess a minimum
4
Alpha-Tocopherol, Beta-Carotene trial and phytochemicals and their identified mecha-protein sequence identity of 30%33, and the the Carotene and Retinol Efficacy Trial5, nisms of action are listed in European Molecular Biology Laboratory-has raised doubts that diet-based cancer (table). These data show European Bioinformatics Institute (prevention can be clinically successful. that phytochemicals with precisely defined ) web service (see Further information) Because these trials were not designed on mechanisms of action based on molecular provides many of the tools necessary for mechanism-based preclinical studies, iden-target identification can be linked to protein sequence searching and align-tifying cancer preventive dietary agents that successful drug discovery.ments34. In addition, the have specific molecular or cellular targets is Phytochemicals, such as resveratrol16–18, (see Further
19–21
thought to be an essential way forwards.(–)-epigallocatechin gallate (EGCG), information) provides databases on protein
22,2324–26
Similar to the development of cancer [6]-gingerol and myricetin, have structures and sequences.therapeutic drugs, the development of recent been reported to directly modulate various A second approach is a compound-based cancer preventive agents is based on the molecular signal transduction pathways, and method that begins with the selection of discovery of precise molecular targets (see research efforts have centred on the effects of putative cancer preventive phytochemical REF. 6 for a review). Because of their success phytochemicals on signalling cascades that candidates based on previous research stud-7–9in clinical trials, drugs such as tamoxifen are known to induce cancer cell death or to ies. From the selected compounds, the most
10–13
and finasteride, which have specific inhibit cancer cell proliferation. However, effective candidates are taken forwards as molecular targets, have been approved by the the specific molecular and cellular targets lead compounds using screening methods US Food and Drug Administration (FDA) need to be identified.such as cell transformation, cell proliferation as cancer preventive agents. In this Opinion and kinase or reporter gene assays. After article, we discuss phytochemical-derived Target discovery methodsselecting lead compounds, candidate target drug discovery and mechanisms by which The overall strategy for discovering molecu-proteins that directly interact with the lead these compounds can modulate distinct tar-lar targets of phytochemicals can involve compounds are identified by ‘reverse dock-get proteins that are involved in oncogenic several approaches depending on whether ing’ on known protein crystal structures
OPiniOn
Molecular targets of phytochemicals
for cancer prevention
CanCer
© 2011 Macmillan Publishers Limited. All rights reserved
of encouraging further research on this important compound and facilitating the identification and development of new phytochemicals for cancer prevention. ...
molecular targets of selected dietary phytochemicals that might slow the ...(2009) Green tea (Camellia sinensis) for the prevention of cancer. ...
phytochemicals and cancer prevention: Nrf2 signaling...With the advent of cellular, molecular, and ...identified as targets of MAPK-mediated ...
PHYTOCHEMICALS FOR CANCER PREVENTION I FOOD PHYTOCHEMICALS FOR CANCER PREVENTION...MOLECULAR NUTRITION FOOD RESEARCH MYCOTOXINS AND FOOD SAFETY NAHRUNG FOOD NEW ...
PHYTOCHEMICALS FOR CANCER PREVENTION I FOOD PHYTOCHEMICALS FOR CANCER PREVENTION...MOLECULAR NUTRITION FOOD RESEARCH MYCOTOXINS AND FOOD SAFETY NAHRUNG FOOD NEW ...
molecular targets, including transcription factors (...2000. Tea polyphenols: Prevention of cancer and ...Cancer chemoprevention with dietary phytochemicals. ...
(e.g., biochemical, genetic, molecular, ...Many phytochemicals present in a diet rich in ... Cancer Epidemiology Biomarkers & Prevention 2003;...
Molecular targets of berry-derived antiin?ammatory ...cial properties of edible berries are phytochemicals...(2009) Perspectives for cancer prevention with ...
natural phytochemicals which are safe and ...[1,2] potentially useful for both prevention and...cancer, by inhibiting specific molecular signaling ...
natural phytochemicals which are safe and ...[1,2] potentially useful for both prevention and...cancer, by inhibiting specific molecular signaling ...
热门文档